Table 1. Summary of Details from RM ANOVAs on List-DMS Performance.
|
% Correct, dose–response function |
|||||
|---|---|---|---|---|---|
| Difficulty | Treatment | Interaction | Response latency | % Task completion | |
| Ketamine | F2,16=42.3; p<0.0001 | F4,32=12.4; p<0.0001 | F8,64=1.4; p>0.05 | F4,32=5.9; p=0.001 | F4,32=6.2; p=0.0008 |
| AZD6765 | F2,14=35.9; p<0.0001 | F3,21=12.4; p<0.0001 | F6,42=12.5; p<0.0001 | F3,21=0.2; p>0.05 | F3,21=4.9; p=0.01 |
| CP101,606 | F2,16=219.3; p<0.0001 | F5,40=32.6; p<0.0001 | F10,80=5.1; p<0.0001 | F5,40=2.1; p=0.09 | F5,40=3.2; p=0.02 |
| BMT-108908 | F2,16=211.6; p<0.0001 | F4,32=39.5; p<0.0001 | F8.64=12.8; p<0.0001 | F4,32=4.4; p=0.006 | F4,32=0.9; p>0.05 |
% correct after 30 min PT data were analyzed with a two-way RM ANOVA. Response latency, % task completion, and pretreatment time were analyzed with one-way RM ANOVAs.